FMCSA Renews Seizure-Related Exemptions for 13 Commercial Drivers
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice lets 13 interstate commercial motor vehicle drivers keep driving despite a medical history involving seizures and the use of anti-seizure medication. The renewed exemptions waive the standard rule that bars drivers with epilepsy or conditions likely to cause loss of consciousness or loss of vehicle control. The practical impact is narrow. It affects the named drivers, their employers, and anyone wishing to comment on the renewals. Comments are due by July 22, 2026.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Renews exemptions for 13 interstate commercial motor vehicle drivers with seizure-related medical histories
- Allows those drivers to continue operating commercial vehicles while taking anti-seizure medication
- Opens a public comment period ending July 22, 2026
Obligations
What this law requires
Submit any comments on the renewed FMCSA seizure-disorder exemptions by the stated comment deadline and identify the appropriate FMCSA docket number when filing.